The FDA has approved lenacapavir as a form of pre-exposure prophylaxis (PrEP), offering a new option for HIV prevention requiring only two shots per year. The post FDA Approves New Version of PrEP—Just Two Shots A Year first appeared on American Sexual Health Association.
